Congratulations to Dr. Katie Burkhouse on her selection as the 2018 New Investigator Award recipient from the American Society of Clinical Psychopharmacology (ASCP).
In a recently-published commentary, researchers discussed the growing interest in transcranial magnetic stimulation (TMS) therapy for post-traumatic stress disorder (PTSD) and major depressive disorder (MDD), and what it brings in patient symptoms.
ENIGMA, the world’s largest brain mapping project, was “born out of frustration,” says neuroscientist Paul Thompson of the University of Southern California in Los Angeles. In 2009, he and geneticist Nicholas Martin of the Queensland Institute of Medical Research in Brisbane, Australia, were chafing at the limits of brain imaging studies.
A new Facebook artificial intelligence software could be a critical tool to lower suicide rates, according to mental health experts. The social network giant has created a new system that will scan posts, comments and live streams on its site for indicators of suicidal thoughts or actions, including responses to questions such as “Are you OK?” or “Can we help?”
A short, simple evaluation can help doctors determine whether a patient with anxiety will respond best to medication or talk therapy, according to new research. Researchers at the University of Illinois at Chicago found that by measuring a patient’s error-related negativity, or ERN, they can determine whether or not a patient is an ideal candidate for cognitive behavioral therapy.
Clinicians and patients often struggle to find the right treatment for anxiety, sometimes cycling through various therapies for months before the patient begins to feel their symptoms improve.